Is Indaptus Therapeutics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: INDP) stock is to Buy INDP stock.
Out of 1 analyst, 0 (0%) are recommending INDP as a Strong Buy, 1 (100%) are recommending INDP as a Buy, 0 (0%) are recommending INDP as a Hold, 0 (0%) are recommending INDP as a Sell, and 0 (0%) are recommending INDP as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year INDP price target, the average INDP price target is $12.00, with the highest INDP stock price forecast at $12.00 and the lowest INDP stock price forecast at $12.00.
The Wall Street analyst predicted that Indaptus Therapeutics's share price could reach $12.00 by Mar 20, 2024. The average Indaptus Therapeutics stock price prediction forecasts a potential upside of 561.16% from the current INDP share price of $1.82.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.